Full Program

Saturday, May 2

AI Translations iconCoronary Theater, Level 1

12:20 PM | Lunchtime Activities
Bridging Past and Future - SAPIEN's Long-Term Advantage
Organized by CVRF and Supported by Educational Grant From Edwards Lifesciences
AI Translations icon AI Translations

Lunchtime Activities

Bridging Past and Future - SAPIEN's Long-Term Advantage

Organized by CVRF and Supported by Educational Grant From Edwards Lifesciences

Saturday, May 2
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Coronary Theater, Level 1
12:20 PM Durability in Real World - PARTNER 3 7 Years & Long-Term Data of AMC
Lecturer: Jung-Min Ahn
12:40 PM Delivering the Future for Structural Heart Disease With Valve-in-Valve Interventions
1:00 PM Discussion and Q&A

AI Translations iconPresentation Theater 1, Level 1

12:20 PM | Lunchtime Activities
Optimizing LDL-C Management for Diverse Patients
Organized by CVRF and Supported by Educational Grant From Organon
AI Translations icon AI Translations

Lunchtime Activities

Optimizing LDL-C Management for Diverse Patients

Organized by CVRF and Supported by Educational Grant From Organon

Saturday, May 2
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Presentation Theater 1, Level 1
Moderator(s): Jung Rae Cho, Yunseok Choi
12:20 PM Interplay LDL-C Management Between Elderly, CKD, and Cardiovascular Risk
Lecturer: Si-Hyuck Kang
12:40 PM Interplay LDL-C Management Between Menopause, Diabetes, and Cardiovascular Risk
Lecturer: Ji Hyun Kim
1:00 PM Panel Discussion

AI Translations iconPresentation Theater 2, Level 1

12:20 PM | Lunchtime Activities
A New Paradigm for Initial Treatment of Hypertension
Organized by CVRF and Supported by Educational Grant From Hanmi Pharmaceutical Co., Ltd.
AI Translations icon AI Translations

Lunchtime Activities

A New Paradigm for Initial Treatment of Hypertension

Organized by CVRF and Supported by Educational Grant From Hanmi Pharmaceutical Co., Ltd.

Saturday, May 2
12:20 PM ~ 1:20 PM * KST (UTC/GMT +9:00)
Presentation Theater 2, Level 1
Moderator(s): Jin Bae Lee, Wook Bum Pyun
12:20 PM Which Patients Benefit From Ultra–Low-Dose Triple Fixed-Dose Combination Therapy?
Lecturer: Jong-Young Lee
12:50 PM Discussion
This program is subject to change without notice.